[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.141.60. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
January 2, 1987

Red Blood Cell Porphobilinogen Deaminase in the Evaluation of Acute Intermittent Porphyria

Author Affiliations

From the Watson Laboratory, Department of Medicine, University of Minnesota (Drs Pierach and Bloomer and Mss Weimer, Cardinal, and Bossenmaier), and Abbott Northwestern Hospital (Dr Pierach), Minneapolis.

From the Watson Laboratory, Department of Medicine, University of Minnesota (Drs Pierach and Bloomer and Mss Weimer, Cardinal, and Bossenmaier), and Abbott Northwestern Hospital (Dr Pierach), Minneapolis.

JAMA. 1987;257(1):60-61. doi:10.1001/jama.1987.03390010064029
Abstract

We measured the activity of the enzyme porphobilinogen deaminase in red blood cells of 222 persons. Ninety-seven of 107 patients with acute intermittent porphyria had enzyme activity below the normal range, whereas 55 of 56 patients with other types of porphyria had normal activity. This underscores the utility of this test in confirming the diagnosis of acute intermittent porphyria. Measurement of enzyme activity in 41 families with acute intermittent porphyria demonstrated that deficient activity is inherited as an autosomal dominant trait. Many latent carriers of the genetic defect were identified by family studies, permitting appropriate precautions to avoid potentially lethal porphyric attacks.

(JAMA 1987;257:60-61)

×